MPI‐CDG from a hepatic perspective: Report of two Egyptian cases and review of literature

Abstract MPI‐CDG is a rare congenital disorder of glycosylation (CDG) which presents with hepato‐gastrointestinal symptoms and hypoglycemia. We report on hepatic evaluation of two pediatric patients who presented to us with gastrointestinal symptoms. Analysis of carbohydrate deficient transferrin (C...

Full description

Bibliographic Details
Main Authors: Tawhida Y. Abdel Ghaffar, Bobby G. Ng, Solaf M. Elsayed, Suzan El Naghi, Sarah Helmy, Nermine Mohammed, Ahmed El Hennawy, Hudson H. Freeze
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:JIMD Reports
Subjects:
Online Access:https://doi.org/10.1002/jmd2.12159
id doaj-b8bb74acd9694e35a7e695786db69adf
record_format Article
spelling doaj-b8bb74acd9694e35a7e695786db69adf2020-11-25T03:57:01ZengWileyJIMD Reports2192-83122020-11-01561202610.1002/jmd2.12159MPI‐CDG from a hepatic perspective: Report of two Egyptian cases and review of literatureTawhida Y. Abdel Ghaffar0Bobby G. Ng1Solaf M. Elsayed2Suzan El Naghi3Sarah Helmy4Nermine Mohammed5Ahmed El Hennawy6Hudson H. Freeze7Yassin Abdel Ghaffar Charity Centre for Liver Disease and Research Cairo EgyptSanford Burnham Prebys Medical Discovery Institute. Human Genetics Program La Jolla California USAYassin Abdel Ghaffar Charity Centre for Liver Disease and Research Cairo EgyptYassin Abdel Ghaffar Charity Centre for Liver Disease and Research Cairo EgyptYassin Abdel Ghaffar Charity Centre for Liver Disease and Research Cairo EgyptYassin Abdel Ghaffar Charity Centre for Liver Disease and Research Cairo EgyptPathology Department Cairo University Cairo EgyptSanford Burnham Prebys Medical Discovery Institute. Human Genetics Program La Jolla California USAAbstract MPI‐CDG is a rare congenital disorder of glycosylation (CDG) which presents with hepato‐gastrointestinal symptoms and hypoglycemia. We report on hepatic evaluation of two pediatric patients who presented to us with gastrointestinal symptoms. Analysis of carbohydrate deficient transferrin (CDT) showed a Type 1 pattern and molecular analysis confirmed the diagnosis of MPI‐CDG. Oral mannose therapy was markedly effective in one patient but was only partially effective in the other who showed progressive portal hypertension.https://doi.org/10.1002/jmd2.12159genetic variantsliver involvementmannoseMPI‐CDGportal hypertension
collection DOAJ
language English
format Article
sources DOAJ
author Tawhida Y. Abdel Ghaffar
Bobby G. Ng
Solaf M. Elsayed
Suzan El Naghi
Sarah Helmy
Nermine Mohammed
Ahmed El Hennawy
Hudson H. Freeze
spellingShingle Tawhida Y. Abdel Ghaffar
Bobby G. Ng
Solaf M. Elsayed
Suzan El Naghi
Sarah Helmy
Nermine Mohammed
Ahmed El Hennawy
Hudson H. Freeze
MPI‐CDG from a hepatic perspective: Report of two Egyptian cases and review of literature
JIMD Reports
genetic variants
liver involvement
mannose
MPI‐CDG
portal hypertension
author_facet Tawhida Y. Abdel Ghaffar
Bobby G. Ng
Solaf M. Elsayed
Suzan El Naghi
Sarah Helmy
Nermine Mohammed
Ahmed El Hennawy
Hudson H. Freeze
author_sort Tawhida Y. Abdel Ghaffar
title MPI‐CDG from a hepatic perspective: Report of two Egyptian cases and review of literature
title_short MPI‐CDG from a hepatic perspective: Report of two Egyptian cases and review of literature
title_full MPI‐CDG from a hepatic perspective: Report of two Egyptian cases and review of literature
title_fullStr MPI‐CDG from a hepatic perspective: Report of two Egyptian cases and review of literature
title_full_unstemmed MPI‐CDG from a hepatic perspective: Report of two Egyptian cases and review of literature
title_sort mpi‐cdg from a hepatic perspective: report of two egyptian cases and review of literature
publisher Wiley
series JIMD Reports
issn 2192-8312
publishDate 2020-11-01
description Abstract MPI‐CDG is a rare congenital disorder of glycosylation (CDG) which presents with hepato‐gastrointestinal symptoms and hypoglycemia. We report on hepatic evaluation of two pediatric patients who presented to us with gastrointestinal symptoms. Analysis of carbohydrate deficient transferrin (CDT) showed a Type 1 pattern and molecular analysis confirmed the diagnosis of MPI‐CDG. Oral mannose therapy was markedly effective in one patient but was only partially effective in the other who showed progressive portal hypertension.
topic genetic variants
liver involvement
mannose
MPI‐CDG
portal hypertension
url https://doi.org/10.1002/jmd2.12159
work_keys_str_mv AT tawhidayabdelghaffar mpicdgfromahepaticperspectivereportoftwoegyptiancasesandreviewofliterature
AT bobbygng mpicdgfromahepaticperspectivereportoftwoegyptiancasesandreviewofliterature
AT solafmelsayed mpicdgfromahepaticperspectivereportoftwoegyptiancasesandreviewofliterature
AT suzanelnaghi mpicdgfromahepaticperspectivereportoftwoegyptiancasesandreviewofliterature
AT sarahhelmy mpicdgfromahepaticperspectivereportoftwoegyptiancasesandreviewofliterature
AT nerminemohammed mpicdgfromahepaticperspectivereportoftwoegyptiancasesandreviewofliterature
AT ahmedelhennawy mpicdgfromahepaticperspectivereportoftwoegyptiancasesandreviewofliterature
AT hudsonhfreeze mpicdgfromahepaticperspectivereportoftwoegyptiancasesandreviewofliterature
_version_ 1724462432348274688